203 related articles for article (PubMed ID: 28663597)
1. Prognostic factors in head and neck cancer: a 10-year retrospective analysis in a single-institution in Italy.
Cadoni G; Giraldi L; Petrelli L; Pandolfini M; Giuliani M; Paludetti G; Pastorino R; Leoncini E; Arzani D; Almadori G; Boccia S
Acta Otorhinolaryngol Ital; 2017 Dec; 37(6):458-466. PubMed ID: 28663597
[TBL] [Abstract][Full Text] [Related]
2. Alcohol and cigarette consumption predict mortality in patients with head and neck cancer: a pooled analysis within the International Head and Neck Cancer Epidemiology (INHANCE) Consortium.
Giraldi L; Leoncini E; Pastorino R; Wünsch-Filho V; de Carvalho M; Lopez R; Cadoni G; Arzani D; Petrelli L; Matsuo K; Bosetti C; La Vecchia C; Garavello W; Polesel J; Serraino D; Simonato L; Canova C; Richiardi L; Boffetta P; Hashibe M; Lee YCA; Boccia S
Ann Oncol; 2017 Nov; 28(11):2843-2851. PubMed ID: 28945835
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and prognostic factors in patients with head and neck cancer: Results from a multicentric study.
Leoncini E; Vukovic V; Cadoni G; Pastorino R; Arzani D; Bosetti C; Canova C; Garavello W; La Vecchia C; Maule M; Petrelli L; Pira E; Polesel J; Richiardi L; Serraino D; Simonato L; Ricciardi W; Boccia S
Cancer Epidemiol; 2015 Jun; 39(3):367-74. PubMed ID: 25770642
[TBL] [Abstract][Full Text] [Related]
4. Tumour stage and gender predict recurrence and second primary malignancies in head and neck cancer: a multicentre study within the INHANCE consortium.
Leoncini E; Vukovic V; Cadoni G; Giraldi L; Pastorino R; Arzani D; Petrelli L; Wünsch-Filho V; Toporcov TN; Moyses RA; Matsuo K; Bosetti C; La Vecchia C; Serraino D; Simonato L; Merletti F; Boffetta P; Hashibe M; Lee YA; Boccia S
Eur J Epidemiol; 2018 Dec; 33(12):1205-1218. PubMed ID: 29779202
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting.
Depenni R; Cossu Rocca M; Ferrari D; Azzarello G; Baldessari C; Alù M; Nolé F; Codecà C; Boscolo G; Piccininni M; Cavalieri S; Bossi P
Eur J Cancer; 2019 Jul; 115():4-12. PubMed ID: 31082692
[TBL] [Abstract][Full Text] [Related]
6. Education, tobacco smoking, alcohol consumption, and IL-2 and IL-6 gene polymorphisms in the survival of head and neck cancer.
López RV; Zago MA; Eluf-Neto J; Curado MP; Daudt AW; da Silva-Junior WA; Zanette DL; Levi JE; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho JF; Boffetta P; Wünsch-Filho V
Braz J Med Biol Res; 2011 Oct; 44(10):1006-12. PubMed ID: 21845339
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and treatment outcomes of Japanese head and neck cancer patients with a second primary cancer.
Yamashita T; Araki K; Tomifuji M; Tanaka Y; Harada E; Suzuki T; Miyamoto S; Shiotani A
Asia Pac J Clin Oncol; 2017 Jun; 13(3):172-178. PubMed ID: 27783469
[TBL] [Abstract][Full Text] [Related]
8. Long-term Survival in Head and Neck Cancer: Impact of Site, Stage, Smoking, and Human Papillomavirus Status.
Du E; Mazul AL; Farquhar D; Brennan P; Anantharaman D; Abedi-Ardekani B; Weissler MC; Hayes DN; Olshan AF; Zevallos JP
Laryngoscope; 2019 Nov; 129(11):2506-2513. PubMed ID: 30637762
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of pretherapeutic laboratory values in head and neck cancer patients.
Peter F; Wittekindt C; Finkensieper M; Kiehntopf M; Guntinas-Lichius O
J Cancer Res Clin Oncol; 2013 Jan; 139(1):171-8. PubMed ID: 23007690
[TBL] [Abstract][Full Text] [Related]
10. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
Chen MM; Colevas AD; Megwalu U; Divi V
Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
[TBL] [Abstract][Full Text] [Related]
11. Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients.
Budnik J; DeNunzio NJ; Singh DP; Milano MT
Clin Lung Cancer; 2020 May; 21(3):195-203. PubMed ID: 30914310
[TBL] [Abstract][Full Text] [Related]
12. Association of Head and Neck Cancer With Mental Health Disorders in a Large Insurance Claims Database.
Lee JH; Ba D; Liu G; Leslie D; Zacharia BE; Goyal N
JAMA Otolaryngol Head Neck Surg; 2019 Apr; 145(4):339-344. PubMed ID: 30816930
[TBL] [Abstract][Full Text] [Related]
13. Quality of life scores as prognostic factors of overall survival in advanced head and neck cancer: analysis of a phase III randomized trial of pemetrexed plus cisplatin versus cisplatin monotherapy.
Urba S; Gatz J; Shen W; Hossain A; Winfree K; Koustenis A; Peterson P; Cohen EE
Oral Oncol; 2012 Aug; 48(8):723-9. PubMed ID: 22414289
[TBL] [Abstract][Full Text] [Related]
14. Oral hygiene and the overall survival of head and neck cancer patients.
Chang CC; Lee WT; Hsiao JR; Ou CY; Huang CC; Tsai ST; Chen KC; Huang JS; Wong TY; Lai YH; Wu YH; Hsueh WT; Wu SY; Yen CJ; Chang JY; Lin CL; Weng YL; Yang HC; Chen YS; Chang JS
Cancer Med; 2019 Apr; 8(4):1854-1864. PubMed ID: 30865385
[TBL] [Abstract][Full Text] [Related]
15. Urban and rural differences in outcomes of head and neck cancer.
Kim JD; Firouzbakht A; Ruan JY; Kornelsen E; Moghaddamjou A; Javaheri KR; Olson RA; Cheung WY
Laryngoscope; 2018 Apr; 128(4):852-858. PubMed ID: 28940575
[TBL] [Abstract][Full Text] [Related]
16. Smoking, Drinking, and Dietary Risk Factors for Head and Neck Cancer in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Participants.
Lander DP; Kallogjeri D; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):249-256. PubMed ID: 38329760
[TBL] [Abstract][Full Text] [Related]
17. Head and neck cancer-specific survival based on socioeconomic status in Asians and Pacific Islanders.
Chu KP; Shema S; Wu S; Gomez SL; Chang ET; Le QT
Cancer; 2011 May; 117(9):1935-45. PubMed ID: 21509771
[TBL] [Abstract][Full Text] [Related]
18. Lymph node ratio as a prognostic factor in head and neck cancer patients.
Chen CC; Lin JC; Chen KW
Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
[TBL] [Abstract][Full Text] [Related]
19. Survival and prognostic factors after pulmonary metastasectomy of head and neck cancer: what are the clinically informative prognostic indicators?
Oki T; Hishida T; Yoshida J; Goto M; Sekihara K; Miyoshi T; Aokage K; Ishii G; Tsuboi M
Eur J Cardiothorac Surg; 2019 May; 55(5):942-947. PubMed ID: 30476033
[TBL] [Abstract][Full Text] [Related]
20. The influence of smoking, age and stage at diagnosis on the survival after larynx, hypopharynx and oral cavity cancers in Europe: The ARCAGE study.
Abrahão R; Anantharaman D; Gaborieau V; Abedi-Ardekani B; Lagiou P; Lagiou A; Ahrens W; Holcatova I; Betka J; Merletti F; Richiardi L; Kjaerheim K; Serraino D; Polesel J; Simonato L; Alemany L; Agudo Trigueros A; Macfarlane TV; Macfarlane GJ; Znaor A; Robinson M; Canova C; Conway DI; Wright S; Healy CM; Toner M; Cadoni G; Boccia S; Gheit T; Tommasino M; Scelo G; Brennan P
Int J Cancer; 2018 Jul; 143(1):32-44. PubMed ID: 29405297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
